Octreotide
CAS No. | 83150-76-9 | Cat. No. | BCP28870 |
Name | Octreotide | ||
Synonyms | Octreotide acetate; Longastatin; SMS-201-995; Octreotide-LAR; SMS 201-995; | ||
Formula | C49H66N10O10S2 | M. Wt | 1019.24 |
Description | Octreotide is a synthetic somatostatin analogue that resembles the native polypeptide in its activity in suppressing levels and activity of growth hormone, insulin, glucagon and many other gastrointestinal peptides. Because its half-life is longer than somatostatin, octreotide can be used clinically to treat neuroendocrine tumors that secrete excessive amounts of growth hormone (acromegaly) or other active hormones or neuropeptides. Octreotide has many side effects including suppression of gall bladder contractility and bile production, and maintenance therapy can cause cholelithiasis, pancreatitis as well as clinically apparent liver injury. | ||
Pathways | GPCR/G Protein | ||
Targets | Somatostatin Receptor |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.